Wound Healing Complications after Neoadjuvant Radiotherapy Combined with Targeted Therapies in Soft Tissue Sarcoma...

Area of Science:

• Oncology
• Radiotherapy
• Molecular Therapy

Background:

• Targeted molecular therapies have advanced soft tissue sarcoma (STS) treatment.
• Data on the benefits and toxicity of targeted therapies in STS, particularly concerning wound healing, is limited.
• Neoadjuvant (NA) radiotherapy (RT) is a common treatment modality for STS.

Purpose of the Study:

• To review potential wound healing complications in STS patients undergoing NA radiotherapy combined with targeted therapies.
• To clarify the safety profile of combined NA RT and targeted therapies in STS.

Main Methods:

• A narrative review of studies was conducted.
• PubMed database was searched for relevant journal articles.
• Inclusion criteria focused on studies examining RT toxicity with targeted therapies in the NA setting for STS.

Main Results:

• Seven studies met the inclusion criteria.
• Delayed wound complication rates were comparable to RT alone.
• One study reported significant toxicity, though not specifically wound-related.

Conclusions:

• Combining NA radiotherapy with targeted therapies appears effective and well-tolerated in STS.
• Current evidence is based on a limited number of studies with low levels of evidence.
• Further high-quality research is necessary to fully elucidate the value of this combined treatment strategy.